Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 158.79
   
  • Change Today:
    $0.89
  • 52 Week High: $267.71
  • 52 Week Low: $155.43
  • Currency: US Dollars
  • Shares Issued: 144.90m
  • Volume: 900,976
  • Market Cap: $23,009m
  • RiskGrade: 259

Latest ShareCast News

Biogen ups forecasts despite weak Alzheimer's drug sales

By Abigail Townsend

Date: Wednesday 20 Oct 2021

(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.

Biogen shares soar as FDA approves Alzheimer's drug

By Abigail Townsend

Date: Tuesday 08 Jun 2021

(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.

Biogen and Sage ink $1.5bn deal to develop anti-depression treatments

By Alexander Bueso

Date: Friday 27 Nov 2020

(Sharecast News) - Biogen has inked a deal with Sage Therapeutics to jointly develop and sell potentially "breakthrough" treatments for major depressive and movement disorders in the US.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 158.79
Change Today $ 0.89
% Change 0.56 %
52 Week High $267.71
52 Week Low $155.43
Volume 900,976
Shares Issued 144.90m
Market Cap $23,009m
RiskGrade 259

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 14
Sell 0
Strong Sell 0
Total 36
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Nov-2024

Time Volume / Share Price
14:43 100 @ $158.79
14:43 100 @ $158.80
14:43 100 @ $158.80
14:43 100 @ $158.80
14:43 100 @ $158.80

Top of Page